RA CAPITAL MANAGEMENT, L.P. - 11 Jan 2024 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director, 10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Issuer symbol
SLDB
Transactions as of
11 Jan 2024
Net transactions value
+$5,000,005
Form type
4
Filing time
12 Jan 2024, 17:01:45 UTC
Previous filing
13 Dec 2023
Next filing
08 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLDB Common Stock Purchase $5,000,005 +904,160 +27% $5.53 4,192,216 11 Jan 2024 See footnotes F1, F2, F4
holding SLDB Common Stock 109,661 11 Jan 2024 See footnotes F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired from the Issuer pursuant to the Securities Purchase Agreement dated January 8, 2024
F2 Held directly by RA Capital Healthcare Fund, L.P. (the "Fund").
F3 Held directly by RA Capital Nexus Fund, L.P. (the "Nexus Fund").
F4 RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Nexus Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

Remarks:

Mr. Shah, a Managing Partner of the Adviser, serves on the Issuer's board of directors.